Got a nightmare neighbour story? Tell us in the comments as we explain how to turn detective when you're house hunting.

Tesla and other EV makers just lost a valuable subsidy. Sales growth in 2026 may disappoint.

The Intratumoral cancer therapies market was valued at USD 151.5 million in 2022 & is expected to grow at a CAGR of 9.9% from 2023-2030. Intratumoral cancer therapies are a type of cancer treatment ...

Tesla’ surged to $460 amid high expectations for tomorrow’s Q3 delivery numbers. Brian and Randy give their prediction of ...

Tesla stock, the biggest gainer among members of the Magnificent Seven in the third quarter, has lost ground in recent days ...

(Reuters) -Tesla's third-quarter deliveries beat analysts' estimates on Thursday as a rush to buy EVs in the U.S. before the ...

Here is a close look at Nio stock, and how analysts expect shares of the EV maker to perform from 2025 to 2030.